TGFB1 and ovarian carcinoma: Beyond its implications in autoimmunity here we have shown, in experiments using ID8 ovarian carcinoma cells, that cancer-cell derived TGFβ also restricts T cell activity more efficiently in response to low affinity as compared to strong agonist peptides.